Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: Point-of-care rapid test versus clinical judgment

Influenza and other Respiratory Viruses

Volumn 10, Issue 2, 2016, Pages 113-121

  Nshimyumukiza, Léon ^a   Douville, Xavier ^a   Fournier, Diane ^a   Duplantie, Julie ^a   Daher, Rana K ^b   Charlebois, Isabelle ^b   Longtin, Jean ^a,b   Papenburg, Jesse ^c   Guay, Maryse ^d   Boissinot, Maurice ^a   Bergeron, Michel G ^a,b   Boudreau, Denis ^a   Gagné, Christian ^a   Rousseau, François ^a,e   Reinharz, Daniel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

^e University Laval   (Canada)

Author keywords

Antiviral treatment; Cost effectiveness; Point of care rapid test; Seasonal influenza; Simulation

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; HEALTH CARE COST; HUMAN; INFLUENZA A; INFLUENZA A RAPID TEST; POINT OF CARE TESTING; PRIORITY JOURNAL; PROGRAM COST EFFECTIVENESS; SEASONAL INFLUENZA; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; ADOLESCENT; CANADA; CHILD; COST BENEFIT ANALYSIS; DECISION MAKING; DISEASE MANAGEMENT; ECONOMICS; INFLUENZA, HUMAN; MIDDLE AGED; POINT OF CARE SYSTEM; SEASON; STATISTICAL MODEL; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CANADA; CHILD; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; HUMANS; INFLUENZA, HUMAN; JUDGMENT; MIDDLE AGED; MODELS, STATISTICAL; POINT-OF-CARE SYSTEMS; SEASONS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84957884872     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12359     Document Type: Article

References (23)

1. Schanzer DL, Tam TW, Langley JM, Winchester BT. Influenza-attributable deaths, Canada 1990-1999. Epidemiol Infect 2007; 135:1109-1116.
2. CDC. MMWR Recomm Rep. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. Center for Disease Control and Prevention (CDC): Atlanta. 1-43.
3. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000; 31:1166-1169.
4. Nicholson KG, Abrams KR, Batham S et al. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds. Health Technol Assess 2014; 18:1-274. doi: 10.3310/hta18360.
5. Lee BY, McGlone SM, Bailey RR et al. To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling. PLoS ONE 2010; 5:e11284.
6. Nagase H, Moriwaki K et al. Cost-effectiveness analysis of oseltamivir for influenza treatment considering the virus emerging resistant to the drug in Japan. Value Health 2009; 3:S62-S65.
7. Durand A, Gagné C, Gardner M.-A, Rousseau F, Giguère Y, Reinharz D. SCHNAPS: a generic population-based simulator for public health purposes; in Proceedings of the 2010 Summer Simulation Multiconference July 12-14, Summer Computer simulation Conference (SCSC). Ottawa, ON: Canada, 2010; 182-189.
8. Heffernan JM, Smith RJ, Wahl LM. Perspectives on the basic reproductive ratio. J R Soc Interface 2005; 2:281-293.
9. Molinari NA, Ortega-Sanchez IR, Messonnier ML et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-5096.
10. Schanzer DL, Zheng H, Gilmore J. Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force Survey. BMC Infect Dis 2011; 11:90. doi: 10.1186/1471-2334-11-90.
11. Mossong J, Hens N, Jit M et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med, 2008; 5:e74.
12. Nichol KL. Efficacy and effectiveness of influenza vaccination. Vaccine 2008; 26(4 Suppl.):D17-D22.
13. Halloran ME, Ferguson NM, Eubank S et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A 2008; 105:4639-4644.
14. Lee BY, Brown ST, Cooley P et al. Vaccination deep into a pandemic wave potential mechanisms for a "third wave" and the impact of vaccination. Am J Prev Med 2010; 39:e21-e29.
15. Wu JT, Riley S, Fraser C, Leung GM. Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med 2006; 3:e361.
16. Rothberg MB, He S, Rose DN. Management of influenza symptoms in healthy adults. J Gen Intern Med 2003; 18:808-815.
17. Monistère de la Santé et des services sociaux [Quebec Ministry of Health and Social services]. Flash influenza, 2012. Santé et Services sociaux: Québec [Health and Social services].
18. Stein J, Louie J, Flanders S et al. Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults. Ann Emerg Med 2005; 46:412-419.
19. Linder JA, Nieva HR, Blumentals WA. Antiviral and antibiotic prescribing for influenza in primary care. J Gen Intern Med 2009; 24:504-510.
20. Gums JG, Pelletier EM, Blumentals WA. Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children. Expert Opin Pharmacother 2008; 9:151-161.
21. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, Low DE Toronto Invasive Bacterial Diseases Network. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45:1568-1575.
22. Jefferson T, Jones MA et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev, 2014; 4:CD008965. doi:10.1002/14651858.CD008965.
23. Michiels B, Van Puyenbroeck K et al. The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews. PLoS ONE 2013; 8:e60348.